Slide

Delivering drug discovery via our unique display technology

Peptide
Discovery

PLAY VIDEO FIND OUT MORE FUNCTIONAL SCREENING DNA Encoded
Peptide Display
Watch now
drive10

What we do

Orbit Discovery offer services for the discovery of peptides and our technologies have been used to identify peptides as the starting point for peptide conjugates, functional peptides, peptidomimetic and small molecule therapeutics.

Our services have been used to identify peptide hits for radionuclide targeting, nucleic acid targeting, components for targeted protein degraders and for GPCR agonists. These applications have been served by a combination of bead based technologies and microfluidics. This combination facilitates high throughput screening and allows the interrogation of a large chemical space. The platform can be configured for affinity screening (targeting binders), but can also be configured for direct functional screens (in particular for agonists) using internally designed reporter cell lines.

Orbits mission is to offer our Partners solutions to identify peptide therapeutic hits by adopting high throughput affinity and functional screening.

iq-image
iq-image
iq-image
Affinity Screening Service

A bead based peptide display engine, using FACS, allows for faster peptide discovery by binding affinity.

Functional Screening Service

The ability to display high peptide copy number allows discovery of functional peptides, such as agonists and antagonists, in primary screens

Target Production Services

The Orbit platform is target agnostic giving access to cell surface receptors, notably GPCRs and ion channels. We have a dedicated team focused on production of targets to ensure quality of starting materials

Single Cell Reporter Assay Services

Using expertise in cell line development and assay development, in conjunction with FACS, high content imaging and microfluidics, the Orbit platform can distinguish a functional response from single cells

Establishing a new standard

Orbit works with both industry and academic Partners to identify hits for existing and novel drug targets where therapeutic peptides can establish a new standard of care.  

drive10
iq-image

Slide

Find out how Orbit can help you with peptide discovery

iq-image